Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of Idiopathic Recurrent Pericarditis With Goflikicept: Phase II/III Study Results.
Myachikova VY, Maslyanskiy AL, Moiseeva OM, Vinogradova OV, Gleykina EV, Lavrovsky Y, Abbate A, Grishin SA, Egorova AN, Schedrova ML, Samsonov MY. Myachikova VY, et al. Among authors: lavrovsky y. J Am Coll Cardiol. 2023 Jul 4;82(1):30-40. doi: 10.1016/j.jacc.2023.04.046. J Am Coll Cardiol. 2023. PMID: 37380301 Free article. Clinical Trial.
Results of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment-Elevation Myocardial Infarction (STEMI).
Abbate A, Van Tassell B, Bogin V, Markley R, Pevzner DV, Cremer PC, Meray I, Privalov DV, Taylor A, Grishin SA, Egorova AN, Ponomar EG, Lavrovsky Y, Samsonov MY; RPH-104 STEMI Study Investigators. Abbate A, et al. Among authors: lavrovsky y. Circulation. 2024 Aug 13;150(7):580-582. doi: 10.1161/CIRCULATIONAHA.124.069396. Epub 2024 Aug 12. Circulation. 2024. PMID: 39133774 Clinical Trial. No abstract available.
Interleukin-1 blockade with RPH-104 (goflikicept) in patients with ST-segment elevation myocardial infarction (STEMI): secondary endpoints from an international, double blind, randomized, placebo-controlled, phase IIa study.
Abbate A, Van Tassell B, Bogin V, Markley R, Pevzner DV, Cremer PC, Meray IA, Privalov DV, Taylor A, Grishin SA, Egorova AN, Ponomar EG, Lavrovsky Y, Samsonov MY. Abbate A, et al. Among authors: lavrovsky y. J Cardiovasc Pharmacol. 2024 Oct 2. doi: 10.1097/FJC.0000000000001635. Online ahead of print. J Cardiovasc Pharmacol. 2024. PMID: 39357146
Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment Elevation Myocardial Infarction: Secondary End Points From an International, Double-Blind, Randomized, Placebo-Controlled, Phase 2a Study.
Abbate A, Van Tassell B, Bogin V, Markley R, Pevzner DV, Cremer PC, Meray IA, Privalov DV, Taylor A, Grishin SA, Egorova AN, Ponomar EG, Lavrovsky Y, Samsonov MY. Abbate A, et al. Among authors: lavrovsky y. J Cardiovasc Pharmacol. 2024 Dec 1;84(6):565-577. doi: 10.1097/FJC.0000000000001635. J Cardiovasc Pharmacol. 2024. PMID: 39642282 Free PMC article. Clinical Trial.
Preclinical Characterization of a Novel Anti-Cancer PD-L1 Inhibitor RPH-120.
Kulikov A, Shipaeva E, Dmitrieva A, Batrak V, Shipunov G, Guy C, Smith J, Zhang R, Zhang M, Duan J, Chestukhin A, Barbashov S, Samsonov M, Lavrovsky Y. Kulikov A, et al. Among authors: lavrovsky y. Front Pharmacol. 2021 Aug 11;12:723038. doi: 10.3389/fphar.2021.723038. eCollection 2021. Front Pharmacol. 2021. PMID: 34456733 Free PMC article.
5-HT6 Receptor Antagonist as an Adjunct Treatment Targeting Residual Symptoms in Patients With Schizophrenia: Unexpected Sex-Related Effects (Double-Blind Placebo-Controlled Trial).
Morozova M, Burminskiy D, Rupchev G, Lepilkina T, Potanin S, Beniashvili A, Lavrovsky Y, Vostokova N, Ivaschenko A. Morozova M, et al. Among authors: lavrovsky y. J Clin Psychopharmacol. 2017 Apr;37(2):169-175. doi: 10.1097/JCP.0000000000000673. J Clin Psychopharmacol. 2017. PMID: 28141622 Clinical Trial.
Add-on clinical effects of selective antagonist of 5HT6 receptors AVN-211 (CD-008-0173) in patients with schizophrenia stabilized on antipsychotic treatment: pilot study.
Morozova MA, Lepilkina TA, Rupchev GE, Beniashvily AG, Burminskiy DS, Potanin SS, Bondarenko EV, Kazey VI, Lavrovsky Y, Ivachtchenko AV. Morozova MA, et al. Among authors: lavrovsky y. CNS Spectr. 2014 Aug;19(4):316-23. doi: 10.1017/S1092852913000394. Epub 2013 Jun 17. CNS Spectr. 2014. PMID: 23768250 Clinical Trial.
38 results